(+/-)-1-[(1-BETA,2-ALPHA,4-BETA)-2,4-BIS-(HYDROXYMETHYL)-CYCLOPENTYL]-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE
Compound with spectra: 1 NMR
![(+/-)-1-[(1-BETA,2-ALPHA,4-BETA)-2,4-BIS-(HYDROXYMETHYL)-CYCLOPENTYL]-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE](/api/compound/CnVdJNvFFGs.png?ph=true&h=300&w=458 "(+/-)-1-[(1-BETA,2-ALPHA,4-BETA)-2,4-BIS-(HYDROXYMETHYL)-CYCLOPENTYL]-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE")
| SpectraBase Compound ID | CnVdJNvFFGs |
|---|---|
| InChI | InChI=1S/C11H16N2O4/c14-5-7-3-8(6-15)9(4-7)13-2-1-10(16)12-11(13)17/h1-2,7-9,14-15H,3-6H2,(H,12,16,17)/t7-,8+,9-/m0/s1 |
| InChIKey | CBWZEGUCVCCNIQ-YIZRAAEISA-N |
| Mol Weight | 240.26 g/mol |
| Molecular Formula | C11H16N2O4 |
| Exact Mass | 240.111007 g/mol |
| Enantiomer InChIKey | CBWZEGUCVCCNIQ-HRDYMLBCSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | DMSO-D6 |
1-[3.beta.-hydroxymethyl-4.alpha.-(methoxymethoxy)cyclopentan-1-yl]pyrimidine-2,4(1H,3H)-dione
VJKCNNVCEZLOQF-XPUUQOCRSA-N
5-iodo-1-[(1S,2R)-2-methylolcyclopentyl]pyrimidine-2,4-quinone
1-[2-(hydroxymethyl)cyclopentyl]-5-iodanyl-pyrimidine-2,4-dione
5-iodo-1-[(1S,2S)-2-methylolcyclopentyl]pyrimidine-2,4-quinone
[(1R,2S)-2-(2,4-dioxopyrimidin-1-yl)cyclopent-3-en-1-yl]methyl acetate
(+/-)-1-[(3'-BETA,5'-BETA)-5'-(HYDROXYMETHYL)-THIAN-3'-YL]-2,4(1H,3H)-PYRIMIDINEDIONE-S-OXIDE;MINOR;(EQUATORIAL-S=O)
6'-CARBA-3'-(2',3'-DIDEOXY)-3'-PROPARGYLTHYMIDINE;CARBA-3'-PROPARGYL-DT
(3R,5S,6R)-1-(5-hydroxy-6-hydroxymethyl-tetrahydropyran-3-yl)-1H-pyrimidine-2,4-dione
| Title | Journal or Book | Year |
|---|---|---|
| Carbocyclic Analogues of Nucleosides from bis-(Hydroxymethyl)-cyclopentane: Synthesis, Antiviral and Cytostatic Activities of Adenosine, Inosine and Uridine Analogues | Chemical and Pharmaceutical Bulletin | 2003 |